Market Overview

Herbalife Shares Edge Higher; Wedbush Boosts Target to $90, Analyst Shows No Concern on Nu Skin Product

Share:
Related HLF
Pershing's Bill Ackman: 'Herbalife's Business Will Ultimately Fail'
Bill Ackman Says He Was Right On Herbalife
Herbalife: The Upcoming Catalyst Expected To Bring The Company Down (Seeking Alpha)
Related NUS
Watch These 8 Huge Put Purchases In Wednesday Trade
Benzinga's Option Alert Recap From October 10
Herbalife: The Upcoming Catalyst Expected To Bring The Company Down (Seeking Alpha)

Shares of Herbalife (NYSE: HLF) are trading up about a percent Friday morning as traders are cheering a boosted price target from Wedbush's Rommel Dionisio.

Dionisio now expects Herbalife shares to rise to $90 over the next year, up from $80 previously.

The analyst believes Herbalife will be buying back additional shares more aggressively on the heels of the recent re-audit conclusion. Dionisio noted the firm's distributor checks are indicating "not even a slight" slowdown in sales growth following the unveiling of a new Nu Skin (NYSE: NUS) product.

Wedbush maintains an Outperform rating on shares of Herbalife.

With Herbalife shares last trading around $79.50, Dionisio's new price target implies potential upside of about 13 percent.

Latest Ratings for HLF

DateFirmActionFromTo
Oct 2017CitigroupMaintainsNeutral
Apr 2017Tigress FinancialInitiates Coverage OnBuy
Mar 2017CitigroupInitiates Coverage OnNeutral

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: Analyst Color News Price Target Analyst Ratings

 

Related Articles (HLF + NUS)

View Comments and Join the Discussion!

Partner Center